Exabis Library
Welcome to the e-CCO Library!
N30: Understanding Inflammatory Bowel Disease Emergency Department Admissions in a Tertiary Referral Inflammatory Bowel Disease Centre in England: A quality Improvement project
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
N31 What factors affect quality of life and psychological well-being in patients with intestinal failure? A systematic review of quantitative studies
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
N31: Nothing about us, without us: Developing a reliable IBD information source on sexual well-being by patients and for patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
N795: Fatigue in IBD must be to compared to the background population – generation of normative data for the IBD-F
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N796: Emotional en social functioning in patients with Crohn's disease needs more attention
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N797: Therapeutic drug monitoring after thiopurine initiation improves drug efficacy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N798: Kinship stigma in community-dwelling people with inflammatory bowel disease: family acknowledgement matters
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N799: Inflammatory bowel disease affects sexual female desire and sexual female excitement
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N800: Statistical comparison of predictors of quality of life in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N801: Patient opinion assessment of a comprehensive clinical tool to improve health-care in inflammatory bowel disease. The Implica-2 project
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N802: Improving care for patients with perianal Crohn's disease; review of a perianal virtual clinic
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N803: Accelerated infusions of biosimilar infliximab are safe and well tolerated and monitoring post-infusion is not required
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N804: An evaluation of patient satisfaction with IBDoc calprotectin home test system
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N805: Do we need to monitor patients after vedolizumab infusion?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N806: Comparison of patient satisfaction between regular care and clinical trial care for IBD patients treated with biologicals
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N807: The use of a pre-screening tool for anti-TNFs in IBD in four North West NHS trusts: a study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N808: Cooking workshops as strategy of health promotion of patients with inflammatory bowel diseases
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N809: IBD control questionnaire: validation and evaluation as part of a virtual biologic clinic in Galway University Hospital, Ireland
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N810: Audit of patient satisfaction with telephone reviews for inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
N811: Infliximab versus adalimumab: clinical and endoscopy response in ulcerative colitis patients. A prospective study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM